Ebola research to be funded from Horizon 2020
€24.4 million from the Horizon 2020 budget will be used for urgently needed Ebola research. This was announced by the European Commission on 23 October 2014. The funding will go to five projects, ranging from a large-scale clinical trial of a potential vaccine, to testing existing and novel compounds to treat Ebola. Funding will be provided via a fast-track procedure, in order to enable research work to start as soon as possible.
Outgoing Research, Innovation and Science Commissioner Máire Geoghegan-Quinn said that “With the WHO bringing the international community together in Geneva [on 23 October], one of the most important messages is that we need to step up medical research on Ebola. These projects enlist the best academic researchers and industry to take the fight to this deadly disease.”
The funding will be provided following proposals from teams across the EU and numerous third countries, which were evaluated by an independent group of experts.
For more information and a list of the selected projects see
Horizon 2020 website: http://ec.europa.eu/programmes/horizon2020/TOP